| Followers | 236 |
| Posts | 10817 |
| Boards Moderated | 0 |
| Alias Born | 07/17/2006 |
Friday, October 04, 2013 8:37:17 PM
zum...
I'm not totally surprised by the results published here...I was initially a big fan of krill oil and owned stock in NEPT...My enthusiasm was based on a study of the effects of krill oil on lipid profiles..The reported results were very impressive, much better than fish oil, and even though krill oil was loaded with DHA, it managed to drop trigs and LDL-C....This study was published in the J. of Alternative Med..
The truth was the results of this study did not satisfy the Friedewald Equation, an equation that gives a mathematical relationship to the various lipid parameters..(and yes I know the Friedewald equation is not accurate when trigs are > 500mg/dl)...but this was not the case here and the Friedewald equation can be modified for higher trigs simply by changing one constant..Also every error involving krill oil's action was in favor of the idea that krill oil was superior to fish oil...the conclusion being the results were falsified..
If the ideas behind the therapeutic benefits of EPA are correct, and the evidence increases daily..We are going to need more EPA than fish oil can comfortably provide..Think of this as a commodity play..Alge looks very good, and the company should become very involved in this..(I think DuPont may be working on this)...
":>) JL
I'm not totally surprised by the results published here...I was initially a big fan of krill oil and owned stock in NEPT...My enthusiasm was based on a study of the effects of krill oil on lipid profiles..The reported results were very impressive, much better than fish oil, and even though krill oil was loaded with DHA, it managed to drop trigs and LDL-C....This study was published in the J. of Alternative Med..
The truth was the results of this study did not satisfy the Friedewald Equation, an equation that gives a mathematical relationship to the various lipid parameters..(and yes I know the Friedewald equation is not accurate when trigs are > 500mg/dl)...but this was not the case here and the Friedewald equation can be modified for higher trigs simply by changing one constant..Also every error involving krill oil's action was in favor of the idea that krill oil was superior to fish oil...the conclusion being the results were falsified..
If the ideas behind the therapeutic benefits of EPA are correct, and the evidence increases daily..We are going to need more EPA than fish oil can comfortably provide..Think of this as a commodity play..Alge looks very good, and the company should become very involved in this..(I think DuPont may be working on this)...
":>) JL
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
